Package Label-principal Display Panel (500 mg (60 Tablets Bottle))
Ranolazine Tablet, Film Coated, Extended Release
Product Images NDC 59651-009
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Ranolazine (NDC 59651-009). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Package Label-principal Display Panel (1000 mg (60 Tablets Bottle))
This is a description of a medication called Ranolazine. It is an extended-release tablet that contains 1000 mg of the medication. The manufacturer is Aurobindo Pharma USA, located in East Windsor, NJ. The usual dosage can be found in the package insert, and the tablets should not be crushed, broken or chewed. The tablets should be stored at 20-25°C. The rest of the text may be a code or information related to manufacturing and printing.*
Chemical Structure (Ranolazine Str)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
